Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)
Clinical trial NCT00078403 · COMPLETED
Trial details
- NCT number
- NCT00078403
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Primary completion
- 2007-05-01
- Enrollment
- 333
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.